For decades, leaders of the Roman Catholic dioceses of New Jersey remained silent on allegations of abuse by clergy members. But this month, the truth will out. Five archdioceses in New Jersey have begun to divulge information related to abuses that stretch back nearly one hundred years. They are finally naming names.
The recent changeover in state attorney generals will not interrupt ongoing investigations into clergy abuse in Roman Catholic dioceses around the country. Offices in New York, Illinois, Michigan, Missouri, Florida, and Delaware which will be lead by new AGs have also reported some of the highest levels priest abuse. And at least 14 attorney generals around the country have confirmed that they are conducting investigations into clergy abuse in their states in the wake of Pennsylvania’s shocking grand jury report, which made international headlines this summer.
While Pennsylvania is still reeling from the findings of the grand jury report into priest sexual abuse throughout the state, Catholic dioceses in other states, including most recently New Jersey, have been conducting their own internal investigations. The latest story involves a list of ten priests who spent their careers in Jesuit schools of New Jersey who have been “credibly” accused of sexual abuse. The list was compiled and released by the USA Northeast Province Jesuits, an organization that represents the Roman Catholic order of priests in north Jersey and several other states.
Recently, Zimmer’s M/L taper hip with Kinectiv and Versys head has been the subject of product liability and personal injury litigation. Like similar hip implant systems from Wright, Johnson & Johnson, and Stryker, the Zimmer system has allegedly caused metallosis in some patients. So far, more than twenty lawsuits have been filed against the manufacturer.
The Catholic Church continues to deal with the fallout from this summer’s shocking grand jury investigation into allegations of rampant sexual abuse by clergy members in several dioceses throughout Pennsylvania. In the latest update, two survivors of alleged child sexual abuse have sued the Philadelphia Archdiocese in order to obtain records of misconduct by priests, along with their work histories.
The Philadelphia Diocese of the Catholic Church has announced that it has created a compensation fund for victims of clergy sexual abuse. The new reparations plan, announced yesterday, will be called the Independent Reconciliation and Reparations program, and will be run by a team responsible for a similar fund in New York.
The bill that would open the window for claims passed the Pennsylvania House of Representatives last month and now awaits Senate review. There are only a few days left in this term for voting on the bill in Harrisburg, so Representative Rozzi of Berks County, who was raped by a priest, and his supporters have ramped up the pressure in Bucks County.
Pennsylvania Attorney General handling the clergy sexual abuse scandal in the state has created a hotline for victims, and the phone is ringing off the hook. The office has received more than a thousand calls, following the naming of more than one thousand victims in the infamous August grand jury report describing widespread sexual abuse by Catholic priests throughout Pennsylvania.
A new study indicates what many within the healthcare industry have increasingly come to suspect about IVC (Inferior Vena Cava) filters: the device is not associated with a reduction in patient mortality. At the same time, the implantation of the filters during catheter-based lytic therapy procedures has significantly increased treatment costs. It seems patients and their insurance providers are paying a lot of money for very little in the way of results.
According to the Chairman of Cardiovascular Medicine at the Cleveland Clinic, approximately 1 out of every 69 of his patients taking canagliflozin for five years will end up with a drug-related amputation. These amputation commonly involve the toe, foot, or part of the leg, and are reportedly twice as likely to occur in patients taking Invokana for several years as opposed to other diabetic drugs.